Economic evaluation of vaccination programs: the impact of herd-immunity
- PMID: 12583457
- DOI: 10.1177/0272989X02239651
Economic evaluation of vaccination programs: the impact of herd-immunity
Abstract
The unique characteristic of vaccination is that it not only reduces the incidence of disease in those immunized but also indirectly protects nonvaccinated susceptibles against infection (produces herd-immunity). The bulk of economic evaluations of vaccination programs continue to use models that cannot take into account the indirect effects produced by herd-immunity. Here, the authors illustrate the importance of incorporating herd-immunity externalities when assessing the cost-effectiveness of vaccination progams. To do this, they compare 2 methods of estimating the benefits of routine mass vaccination: one that includes herd-immunity (dynamic approach) and one that does not (static approach). Finally, they use the results to clarify a number of misconceptions that are common in the literature concerning herd-immunity and dynamical effects produced by models.
Similar articles
-
Economic evaluation of varicella vaccination in Spain: results from a dynamic model.Vaccine. 2006 Nov 17;24(47-48):6980-9. doi: 10.1016/j.vaccine.2006.04.051. Epub 2006 May 4. Vaccine. 2006. PMID: 16860909
-
Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.Vaccine. 2004 Oct 22;22(31-32):4203-14. doi: 10.1016/j.vaccine.2004.05.003. Vaccine. 2004. PMID: 15474710
-
The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.Vaccine. 2012 Nov 6;30(48):6766-76. doi: 10.1016/j.vaccine.2012.09.025. Epub 2012 Sep 21. Vaccine. 2012. PMID: 23000223
-
The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Clin Ther. 2008. PMID: 18343273 Review.
-
Cost–effectiveness of catch-up programs in human papillomavirus vaccination.Expert Rev Vaccines. 2010 Oct;9(10):1187-201. doi: 10.1586/erv.10.108. Expert Rev Vaccines. 2010. PMID: 20923269 Review.
Cited by
-
Risk perception and subsidy policy-based voluntary vaccination driven by multiple information sources.PLoS One. 2022 Oct 13;17(10):e0276177. doi: 10.1371/journal.pone.0276177. eCollection 2022. PLoS One. 2022. PMID: 36227953 Free PMC article.
-
Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information.Med Decis Making. 2013 Apr;33(3):407-14. doi: 10.1177/0272989X12453503. Epub 2012 Aug 27. Med Decis Making. 2013. PMID: 22927697 Free PMC article.
-
Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination.Pharmacoeconomics. 2008;26(1):45-56. doi: 10.2165/00019053-200826010-00005. Pharmacoeconomics. 2008. PMID: 18088158
-
Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.BMC Med. 2011 Jul 8;9:84. doi: 10.1186/1741-7015-9-84. BMC Med. 2011. PMID: 21740545 Free PMC article. Review.
-
Cost-effectiveness analysis of diarrhoea management approaches in Nigeria: A decision analytical model.PLoS Negl Trop Dis. 2017 Dec 19;11(12):e0006124. doi: 10.1371/journal.pntd.0006124. eCollection 2017 Dec. PLoS Negl Trop Dis. 2017. PMID: 29261649 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources